x
ServiziMenu principaleHome
You are here: Home > Events > Future Events > ESO-ESGO-ENYGO Course on Pathology of Gynaecological Tumors
Print

Description

IMPORTANT INFORMATION

We plan to organize the event as an in-person meeting.

In case the situation related to COVID pandemic will have restriction on travel, the course will be moved online.

INTRODUCTION

The ESO-ESGO-ENYGO Course on pathology of gynaecological tumours has been designed for pathologists, gynecological oncologists and medical oncologists, with the aim to provide an update on the State of-the art diagnostics as well as an overview of the latest advances in the field of gynaecological oncology.

Moreover, spotlight lectures will cover specific issues related to particular situations such as diagnostic dilemmas in challenging cases.

Practical training will be offered in the frame of „tumour board“ sessions in a mode of case presentations, prepared and presented by participants and discussed with the faculty.

LEARNING OBJECTIVES

  • Update on the latest advances in diagnostic procedures in gynaecological cancers
  • Improve practical skills in solving diagnostic dilemas/problems and setting the best diagnosis and treatment for gynaecological cancer patients
  • Update on the latest advances and on the state-of- the-art treatment options
  • Debate on controversies and challenges in gynaecological cancer diagnostics and treatment
  • Learn about the management of specific situation

MAIN TOPICS

  • Gyneacological cancer pathology
  • Update on standard and new diagnostic and treatment options for gynaecological cancer
  • Pathological diagnosis and treatment of gynaecological cancer – closer than ever
The Course is an ESO-ESGO-ENYGO joint event   

      
 

 

 

 

General Information

ORGANISING SECRETARIAT
Alice Ciocchini
European School of Oncology
Via Turati 29, 20121, Milan (IT)
Email: aciocchini@eso.net

Dolores Knupfer
European School of Oncology
Piazza Indipendenza 1, Bellinzona (CH)
Email: dknupfer@eso.net

CME ACCREDITATION AND CERTIFICATE
Application for CME recognition has been submitted to the Accreditation Council of Oncology in Europe (ACOE) and to the European Accreditation Council for Continuing Medical Education (EACCME), an institution of the European Union of Medical Specialists (UEMS).
EACCME credits are recognised by the American Medical Association towards the Physician’s Recognition Award (PRA).
Information on the status of the application can be obtained from the organising secretariat.

ESCO CREDITS

Being selected to take part in this ESO actvity gives participants eligibility to enrol in ESCO - the College of the European School of Oncology.
It also enables ESCO students to earn ESCO credits and therefore access more ESCO benefits. Full and active participation in this course earns participants 9 ESCO credits.
Visit www.esco.org for information on how to join ESCO.


PRIVACY POLICY
In the event of registrations to events held in partnership with other entities (clearly specified in the title of the event or by sending a request to ESO), please be aware that the partner should be considered joint data controller and that the consents provided to ESO will be transferred to the partner as well. Any subsequent consent modifications will need to be communicated to the partner directly.

Application

Admittance to the course is by competitive application.

- The fee for successful applicants is 120€
- Selected participants coming from low-middle-income Countries (as defined by the World Bank) will have to cover a discounted fee of 80€

Non-local participants will be offered accommodation for the period 17-19 November 2021. Travel will be covered by participants.

Applications made as a team from the same institute - i.e. at least two members: pathologist  and surgeon, pathologist and medical oncologist, pathologist and radiotherapist etc. - to promote multisdiciplinarity are welcome.

Full participation is compulsory throughout the course for all participants.

The course will be entirely in English and fluency in English is necessary for admission.

HOW TO APPLY

  • Letter describing motivation for attending the event– please mention here if you are participating with a team member and add their name
  • Short CV – complete template provided
  • Supporting letter from Head of Department/Mentor
  • Abstract (complete template provided) with proposed presentation of a pathological case relating to one of the main themes of the course:
    • Cervix
    • Endometrial
    • Ovary

The abstract should be presented in the form of a brief case discussion and describe:

  • Diagnostic considerations
  • Treatment
  • Outcome (follow-up)
  • Up to three questions that the author proposes for discussion by the faculty and participants

APPLICATION DEADLINE:   4th July 2021

TEMPLATES

  • Download HERE your CV template
  • Download HERE your Abstract template

Programme

17 November

18:00 Registration
19:30 Welcome dinner

18 November

8:30 Welcome address and general introduction
9:00 Cervical cancer - part 1
  9:00 New aspects on adenocarcinoma of the cervix
  9:30 Diagnosis of microinvasive cervical cancer
    Challenge for colposcopist
    Challenge for pathologist
  10:10 Rare histological types:
    Challenge for pathologist
    Challenge for clinician
10:50 Coffee break
11:20 Cervical cancer - part 2
  11:20 Fertility preservation in early cervical cancer: to whom it should be offered
  11:50 Clinical and pathological aspects of lymphnode staging in cervical cancer
    Challenge the pathologist
    Challenge the clinician
12:30 Tumour board: 4 Selected cases presented by participants and discussed with the faculty
13:30 Lunch
14:30 Endometrial cancer
  14:30 Uterine sarcoma
    Challenge the pathologist
    Challenge the clinician
  15:10 Different methods of biopsies: limitations for diagnosis?
  16:20 Molecular classification of endometrial cancer – does pathology influence the treatment?
    View of pathologist
    View of clinician
17:00 Coffee break
17:30 Tumour board: 4 Selected cases presented by participants and discussed with the faculty

19 November

8:30 Ovarian cancer - part 1
  8:30 Borderline tumors: a never-ending challenge
    View of pathologist
    View of clinician
  9:10 Evaluation of response after neoadjuvant treatment (CRS)
  9:40 Management of non-chemo-sensitive tumors: an unresolved issue
    View of clinician
    View of pathologist
10:20 Coffee break
10:30 Ovarian cancer - part 2
  10:30 Clinical implementation of ovarian cancer molecular profile: is it the way to the personalized treatment?
11:00 Tumour board: 4 Selected cases presented by participants and discussed with the faculty
12:00 Learning self-assessment test
12:30 Best clinical case award, farewell address and wrap up